Pub. Date : 2008 Aug
PMID : 18535816
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. | Rosuvastatin Calcium | apolipoprotein B | Homo sapiens |
| 2 | RESULTS: Rosuvastatin 20 mg significantly reduced plasma LDL-cholesterol, triacylglycerol and total ApoB. | Rosuvastatin Calcium | apolipoprotein B | Homo sapiens |
| 3 | Rosuvastatin did not change the production rates of VLDL2-, IDL- or LDL-, but did reduce VLDL1-ApoB production rate (12.4 +/- 4.5 vs 19.5 +/- 8.4 mg kg(-1) day(-1), p = 0.035). | Rosuvastatin Calcium | apolipoprotein B | Homo sapiens |